Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
102
NCT03901690
Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study
Phase: Phase 3
Role: Collaborator
Start: Aug 27, 2019
Completion: May 20, 2020